Disease-modifying pharmacological approaches to correcting basal forebrain cholinergic neuronal (BFCN) dysfunction and degeneration

Neuropsychopharmacology. 2022 Jan;47(1):405-406. doi: 10.1038/s41386-021-01135-x.
No abstract available

Publication types

  • News
  • Research Support, N.I.H., Extramural

MeSH terms

  • Alzheimer Disease*
  • Basal Forebrain*
  • Cholinergic Agents
  • Cholinergic Neurons
  • Humans

Substances

  • Cholinergic Agents